HNN3.0
Register
Register
Register

Project cooperationUpdated on 26 November 2025

Novel big-data AI-assisted neuroprotection drug discovery

CEO at CBX Therapeutics

Beer Sheva, Israel

About

A collaborative project is proposed to establish a comprehensive big-data, AI-driven framework for discovering novel neuroprotective solutions.

The initiative will integrate biological predictive models with advanced in-silico, multisystem target identification to uncover actionable mechanisms in neurodegeneration.

Candidate solutions will be prioritized through AI-assisted in-silico and in-vitro confirmation workflows that enable rapid experimental validation. These datasets will feed reinforcement-learning loops that continuously refine predictive accuracy and therapeutic potential.

The project invites partners interested in advancing this integrated discovery ecosystem toward next-generation interventions in brain health and Parkinson’s disease.

Organisation

CBX Therapeutics

Start-up

Beer Sheva, Israel

Similar opportunities

  • Project cooperation

    Expertise in insilico model

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Davide Baroli

    Research scientist at Ricam oeaw

    Linz, Austria

  • Project cooperation

    Biomimetic profiling

    • Partner seeks Consortium/Coordinator

    Darija Obradovic Jovcic

    Research Associate Professor at Institute of Physics Belgrade, National Institute of the Republic of Serbia (Biomimetics Laboratory)

    Belgrade, Serbia

  • Project cooperation

    CircRNA Biomarkers for Post-Infection Neurological Conditions

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Lalit Kaurani

    Group Leader at Institute of Physiology of the Czech Academy of Sciences

    Prague, Czech Republic